BR0116065A - Cloridrato de 2-butil-3-(4-[3-(dibutilamino)propóxi]benzoil)-5nitro-b enzofurano e sua preparação - Google Patents

Cloridrato de 2-butil-3-(4-[3-(dibutilamino)propóxi]benzoil)-5nitro-b enzofurano e sua preparação

Info

Publication number
BR0116065A
BR0116065A BR0116065-6A BR0116065A BR0116065A BR 0116065 A BR0116065 A BR 0116065A BR 0116065 A BR0116065 A BR 0116065A BR 0116065 A BR0116065 A BR 0116065A
Authority
BR
Brazil
Prior art keywords
propoxy
nitro
dibutylamino
benzoyl
butyl
Prior art date
Application number
BR0116065-6A
Other languages
English (en)
Other versions
BR0116065B1 (pt
Inventor
Michel Biard
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR0116065A publication Critical patent/BR0116065A/pt
Publication of BR0116065B1 publication Critical patent/BR0116065B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"CLORIDRATO DE 2-BUTIL-3-(4-[3-(DIBUTILAMINO)PROPóXI]BENZOIL)-5-NITRO-B ENZOFURANO E SUA PREPARAçãO". A invenção refere-se ao cloridrato de 2-butil-3-(4-[3-(dibutilamino) propóxi]benzoil)-5-nitro-benzofurano, a sua preparação e a sua utilização como intermediário de síntese notadamente para preparar o 2-butil-3-(4-[3(dibutilamino) propóxi]benzoil)-5-nitro-benzofurano que é intermediário para a dronedarona.
BRPI0116065-6A 2000-12-11 2001-12-10 Processos de preparação do cloridrato de 2-butil-3-(4-[3-(dibutilamino)propóxi]benzoil)-5nitro-benzofurano, do 2-butil-3-(4-[3-(dibutilamino)propóxi]benzoil)-5nitro-benzofurano, da dronedarona e de seus sais farmaceuticamente aceitáveis BR0116065B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0016069 2000-12-11
FR0016069A FR2817865B1 (fr) 2000-12-11 2000-12-11 Derive aminoalkoxybenzoyle sous forme de sel, son procede de preparation et son utilisation comme intermediaire de synthese
PCT/FR2001/003900 WO2002048078A1 (fr) 2000-12-11 2001-12-10 Chlorhydrate du 2-butyl-3-(4-'3-(dibutylamino)propoxy!benzoyl)-5-nitro-benzofurane et sa preparation

Publications (2)

Publication Number Publication Date
BR0116065A true BR0116065A (pt) 2003-10-28
BR0116065B1 BR0116065B1 (pt) 2014-03-25

Family

ID=8857481

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0116065-6A BR0116065B1 (pt) 2000-12-11 2001-12-10 Processos de preparação do cloridrato de 2-butil-3-(4-[3-(dibutilamino)propóxi]benzoil)-5nitro-benzofurano, do 2-butil-3-(4-[3-(dibutilamino)propóxi]benzoil)-5nitro-benzofurano, da dronedarona e de seus sais farmaceuticamente aceitáveis

Country Status (21)

Country Link
US (1) US6846936B2 (pt)
EP (1) EP1351907B1 (pt)
JP (2) JP4437004B2 (pt)
CN (2) CN1295200C (pt)
AR (1) AR035663A1 (pt)
AT (1) ATE345319T1 (pt)
AU (1) AU2002217227A1 (pt)
BR (1) BR0116065B1 (pt)
CA (1) CA2429268C (pt)
CZ (1) CZ303489B6 (pt)
DE (1) DE60124587T2 (pt)
DK (1) DK1351907T3 (pt)
ES (1) ES2276741T3 (pt)
FR (1) FR2817865B1 (pt)
HK (1) HK1055944A1 (pt)
HR (1) HRP20030471B1 (pt)
HU (1) HUP0500981A3 (pt)
MX (1) MXPA03005223A (pt)
PL (1) PL206029B1 (pt)
SK (1) SK287770B6 (pt)
WO (1) WO2002048078A1 (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356054B (en) * 2004-03-31 2012-01-11 Activus Pharma Co Ltd Quaternary ammonium compound, producing method the
GB0719180D0 (en) * 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
KR20100135909A (ko) 2008-04-17 2010-12-27 사노피-아벤티스 심혈관성 입원 또는 사망을 예방하는데 사용하기 위한 약제의 제조에 있어서의 드로네다론의 용도
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
EP2246341A1 (en) 2009-01-23 2010-11-03 Lonza Ltd. Process for preparing 2-Alkyl-3-aroyl-5-nitro-benzofurans
PL2417099T3 (pl) * 2009-04-08 2016-06-30 Cambrex Karlskoga Ab Nowy sposób wytwarzania hydroksyloamin i leki
UY32656A (es) 2009-05-27 2010-12-31 Sanofi Aventis Procedimiento para producir benzofuranos
UY32657A (es) 2009-05-27 2010-12-31 Sanofi Aventis Procedimiento para la fabricación de productos intermedios de dronedarona
CN101993427B (zh) * 2009-08-26 2012-10-10 成都伊诺达博医药科技有限公司 一种制备决奈达隆的方法
HUP0900759A2 (en) 2009-12-08 2011-11-28 Sanofi Aventis Novel process for producing dronedarone
HUP1000010A2 (en) 2010-01-08 2011-11-28 Sanofi Sa Process for producing dronedarone
IT1398317B1 (it) * 2010-02-23 2013-02-22 Chimico Internaz Spa Lab Nuovo procedimento per la preparazione del dronedarone.
FR2957079B1 (fr) 2010-03-02 2012-07-27 Sanofi Aventis Procede de synthese de derives de cetobenzofurane
EP2371824A1 (en) * 2010-03-08 2011-10-05 Ratiopharm GmbH Crystalline dronedarone salts
FR2958290B1 (fr) 2010-03-30 2012-10-19 Sanofi Aventis Procede de preparation de derives de sulfonamido-benzofurane
FR2958291B1 (fr) 2010-04-01 2013-07-05 Sanofi Aventis Procede de preparation de derives d'amino-benzofurane
HUP1000330A2 (en) * 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2012004658A2 (en) 2010-07-09 2012-01-12 Frichem Private Limited Process for preparation of n-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide, acid addition salts and product thereof
WO2012007959A1 (en) * 2010-07-16 2012-01-19 Glenmark Generics Limited Process for preparing dronedarone
FR2962731B1 (fr) 2010-07-19 2012-08-17 Sanofi Aventis Procede de preparation de derives d'amino-benzoyl-benzofurane
FR2963006B1 (fr) 2010-07-21 2013-03-15 Sanofi Aventis Procede de preparation de derives de nitro-benzofurane
HUP1000386A2 (en) 2010-07-22 2012-05-29 Sanofi Sa Novel process for producing dronedarone
WO2012032545A1 (en) * 2010-09-08 2012-03-15 Cadila Healthcare Limited Processes for preparing dronedarone and its intermediates
EP2447256A1 (en) 2010-10-21 2012-05-02 Laboratorios Lesvi, S.L. Process for obtaining dronedarone
CN102070579B (zh) * 2011-01-19 2016-03-09 上海医药工业研究院 2-正丁基-3-(4-取代丙氧基苯甲酰基)-5-取代氨基苯并呋喃的制备方法
CN102070578B (zh) * 2011-01-19 2015-10-14 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-烷酰基氨基苯并呋喃的制备方法
CN102070581B (zh) * 2011-01-19 2015-11-25 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-氨基苯并呋喃的制备
CN102070580B (zh) * 2011-01-19 2015-05-20 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-取代氨基苯并呋喃的制备
WO2012120544A2 (en) 2011-03-10 2012-09-13 Sun Pharmaceutical Industries Ltd. PROCESS FOR N-[2-n-BUTYL-3-[4-[3-(DI-n-BUTYLAMINO) PROPOXY]ENZOYL]BENZOFURAN-5-YL]METHANESULFONAMIDE HYDROCHLORIDE
CN102690249B (zh) * 2011-03-22 2014-09-17 江苏康缘药业股份有限公司 一种决奈达隆的制备方法
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
HUP1100166A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Reductive amination process for preparation of dronedarone using amine intermediary compound
WO2013014479A1 (en) 2011-07-26 2013-01-31 Sanofi Reductive animation process for preparation of dronedarone using aldehyde intermediary compound
WO2013014480A1 (en) 2011-07-26 2013-01-31 Sanofi Process for preparation of dronedarone using amide intermediary compound
WO2013014478A1 (en) 2011-07-26 2013-01-31 Sanofi Reductive amination process for preparation of dronedarone using carboxyl intermediary compound
ITMI20111672A1 (it) * 2011-09-16 2013-03-17 Olon Spa Metodo efficiente per la preparazione di dronedarone cloridrato
FR2983198B1 (fr) * 2011-11-29 2013-11-15 Sanofi Sa Procede de preparation de derives de 5-amino-benzoyl-benzofurane
EP2617718A1 (en) 2012-01-20 2013-07-24 Sanofi Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
US9221778B2 (en) 2012-02-13 2015-12-29 Sanofi Process for preparation of dronedarone by removal of hydroxyl group
WO2013121234A1 (en) 2012-02-14 2013-08-22 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
WO2013124745A1 (en) 2012-02-22 2013-08-29 Sanofi Process for preparation of dronedarone by oxidation of a hydroxyl group
WO2013178337A1 (en) * 2012-05-31 2013-12-05 Sanofi Process for preparation of dronedarone by grignard reaction
CN102675267B (zh) * 2012-06-07 2015-05-13 济南富创医药科技有限公司 盐酸决奈达隆及其中间体的制备方法
CN108164411B (zh) * 2017-12-29 2021-03-02 苏州汶颢微流控技术股份有限公司 基于微反应器制备对庚氧基苯甲酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947470A (en) * 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4024273A (en) * 1974-06-20 1977-05-17 Smithkline Corporation Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
US5631369A (en) * 1994-08-31 1997-05-20 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
CZ20031611A3 (cs) 2003-08-13
JP2009024007A (ja) 2009-02-05
WO2002048078A1 (fr) 2002-06-20
CN1479706A (zh) 2004-03-03
PL206029B1 (pl) 2010-06-30
AR035663A1 (es) 2004-06-23
JP2004515536A (ja) 2004-05-27
ES2276741T3 (es) 2007-07-01
PL364774A1 (en) 2004-12-13
CA2429268C (fr) 2011-02-01
CZ303489B6 (cs) 2012-10-17
CN1295200C (zh) 2007-01-17
SK7272003A3 (en) 2003-11-04
CA2429268A1 (fr) 2002-06-20
US6846936B2 (en) 2005-01-25
DE60124587T2 (de) 2007-09-20
HUP0500981A2 (en) 2006-03-28
AU2002217227A1 (en) 2002-06-24
HRP20030471B1 (en) 2011-07-31
ATE345319T1 (de) 2006-12-15
CN100371314C (zh) 2008-02-27
DE60124587D1 (de) 2006-12-28
FR2817865A1 (fr) 2002-06-14
JP4437004B2 (ja) 2010-03-24
CN1769262A (zh) 2006-05-10
EP1351907A1 (fr) 2003-10-15
HK1055944A1 (en) 2004-01-30
DK1351907T3 (da) 2007-03-26
HUP0500981A3 (en) 2012-09-28
BR0116065B1 (pt) 2014-03-25
MXPA03005223A (es) 2004-04-20
FR2817865B1 (fr) 2005-02-18
SK287770B6 (sk) 2011-09-05
EP1351907B1 (fr) 2006-11-15
US20040010032A1 (en) 2004-01-15
HRP20030471A2 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
BR0116065A (pt) Cloridrato de 2-butil-3-(4-[3-(dibutilamino)propóxi]benzoil)-5nitro-b enzofurano e sua preparação
FR2732020B1 (fr) Synthese de 3-(4-(2-aminoethoxy)benzoyl)-2-aryl-6- hydroxybenzo(b)thiophenes
HRP20030472B1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
LU91960I2 (fr) Télaprévir et chaque forme thérapeutiquement équivalente de celui-ci protégéé par le brevet de base,tels que des sels pharmaceutiquement acceptables et/ou solvates de télaprévir ou solvates de tels sels
NO20023997L (no) 2-okso-1-pyrrolidinderivater, fremgangsmåter for deres fremstilling, og deres anvendelse
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
GT199700052A (es) Sales metanosulfonatode5-(2-4-(1,2-benzoisotiazol-3-il)-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-onadihidratadas
CY1107736T1 (el) Υποκατεστημενα και μη υποκατεστημενα βενζοξαθειαζολια, ως και εκπορευομενες απο αυτα ενωσεις
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
PT1246813E (pt) Metodo para a preparacao de citalopram
NO20013215D0 (no) 5HT1 antagonister for antidepressiv terapi
ATE255105T1 (de) Serotonerge benzofurane
NO20004271D0 (no) Benzylpiperazinyl- og benzylpiperidinyl etanonderivater, deres fremstilling og deres anvendelse som dopamin D4 reseptorantagonister
NO20013891D0 (no) Sammensetninger omfattende citalopram
DE60002583D1 (de) Benzofurylpiperazine als serotonin-agonisten
BR0003625B1 (pt) absorvente higiÊnico resistente À compressço.
DE50108831D1 (de) Hubstütze
NO20025474D0 (no) Benzofuranderivater
CL2009001914A1 (es) Uso de una combinacion de (s)-n-[2-(1,6,7,8-tetrahidro-2h-indeno[5,4-b]furan-8-il)etil]propionamida y una o mas drogas seleccionadas de donepezilo, nivalina, rivastigmina, tacrina y memantine para prevenir o tratar la demencia (divisional de la solicitud 748-06).
NO20044878L (no) Keramisk ror for vakuumstrombryter
BRPI0414522A (pt) método e aparelho para direcionar configuração de rede
NO20014937D0 (no) Naturlige pseudomycinprodukter
DK1223914T3 (da) Oralt desintegrerende sammensætning, der omfatter mirtazapin
BR9904222A (pt) Exaustor para vaso sanitário
HUP0103031A2 (hu) Állítható tartó üreges padlók számára

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]

Free format text: REFERENCIA RPI 2224 DE 20/08/2013, DEVIDO A INCORRECAO NA JUNTADA, EM FORMATO DIGITAL, DOS DOCUMENTOS ENCAMINHADOS PELA ANVISA.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/03/2014, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.